Castle biosciences stock.

Nov 14, 2023 · Castle Biosciences Inc Stock Price History. Castle Biosciences Inc’s price is currently up 22.54% so far this month. During the month of November, Castle Biosciences Inc’s stock price has reached a high of $19.70 and a low of $15.28. Over the last year, Castle Biosciences Inc has hit prices as high as $29.59 and as low as $9.26. Year to ... Health has made over 7 trades of the Castle Biosciences stock since 2019, according to the Form 4 filled with the SEC. Most recently Health sold 250,000 units of CSTL stock worth $8,625,000 on 12 May 2020.Nov 2, 2023 · Overview. Castle Biosciences is improving health through our innovative tests that guide patient care. For the diseases that our portfolio of tests cover, we believe the traditional approach to developing a treatment plan for cancers and other diseases using clinical and pathology factors alone is inadequate and can be improved by incorporating the personalized information our tests provide. Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire AltheaDx, Inc. (AltheaDx). AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that ...

Leadership: Castle Biosciences. Stock and Other Ownership Interests: Castle Biosciences. Patents, Royalties, Other Intellectual Property: Patents with Castle Biosciences. No other potential conflicts of interest were reported. OPTIONS & TOOLS. Export Citation: Track Citation: Add To Favorites: Rights & Permissions; COMPANION …Mr. Spiess CSTL stock SEC Form 4 insiders trading. Bernhard has made over 9 trades of the Castle Biosciences stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 1,500 units of CSTL stock worth $29,820 on 10 December 2021.. The largest trade he's ever made was selling 40,000 units of Castle …The primary residents of European castles during the Middle Ages were the lord and lady of the realm. These might be royalty or simply the liege lords of the district where the castle was built.

Castle Biosciences-stock Castle Biosciences Inc Registered Shs Stock , CSTL 19.78 + +% After-market 04:20:00 PM NAS Add to watchlist 19.78 -0.10 -0.50% Official Close …Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to …

2.64%. $8.71B. CSTL | Complete Castle Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Castle Biosciences Inc (CSTL) Stock Expected to Experience Positive Growth on November 3, 2023: Analysts Predictions and Ratings. On November 3, 2023, Castle Biosciences Inc (CSTL) stock is expected to experience positive growth, according to analysts. The 8 analysts offering 12-month price forecasts for CSTL have a median …Employment: Castle Biosciences. Stock and Other Ownership Interests: Castle Biosciences. Patents, Royalties, Other Intellectual Property: Chimeric antigen receptors (CARs) and CAR-expressing T cells are provided that can specifically target cells that express an elevated level of a target antigen. Likewise, methods for specifically …Castle Biosciences Inc Registered Shs's market capitalization is $534.59 M by 26.91 M shares outstanding. Castle Biosciences Stock Snapshot 16.00Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...

... stock price multiplied by the number of shares outstanding. Castle Biosciences net worth as of November 17, 2023 is $0.53B. Compare CSTL With Other Stocks ...

June 11, 2023 at 5:04 AM · 3 min read. Whilst it may not be a huge deal, we thought it was good to see that the Castle Biosciences, Inc. ( NASDAQ:CSTL) Independent Director, Ellen Goldberg ...

But note: Castle Biosciences may not be the best stock to buy.So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).. Please note, the ...The Castle Biosciences stock prediction for 2025 is currently $ 28.00, assuming that Castle Biosciences shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 40.19% increase in the CSTL stock price. Following this news, Relmada’s stock price fell nearly 80% to close at $6.48 per share on October 13, 2022. ... Castle Biosciences, Inc. (NASDAQ: CSTL)1 Nis 2022 ... TAKEAWAY: 48% Chance Of Rise Over Next 1M For CSTL · CSTL Stock's Historical Performance Compared · How has Castle Biosciences (CSTL) stock price ...2 Ağu 2023 ... Castle Biosciences CSTL · Profile · Stock Chart · Financial Statements · Financial Ratios · Other stocks of industry "Diagnostics research" ...On November 2, 2023, Castle Biosciences (NASDAQ:CSTL) released its Q3 2023 financial report, showcasing impressive results. The company reported a loss of $ (0.26) per share, surpassing the analyst consensus estimate of $ (0.76) by an impressive 65.79 percent. This marks a remarkable 66.23 percent increase in losses compared to the same period ...Castle Biosciences Market Cap: 537.40M, Enterprise value: 484.98M, P/E: -8.76, PEG ratio: 0.08, EPS: -2.84, Revenue: 192.00M, EBITDA: -64.35M, ...

Castle Biosciences Inc’s Stock Price as of Market Close. As of October 25, 2023, 4:00 PM, CST, Castle Biosciences Inc’s stock price was $12.66. Castle Biosciences Inc is down 4.24% from its previous closing price of $13.22. During the last market session, Castle Biosciences Inc’s stock traded between $12.78 and $13.25. …The estimated net worth of David S. Kabakoff is at least $3.83 million as of June 22nd, 2020. Mr. Kabakoff owns 212,178 shares of Castle Biosciences stock worth more than $3,831,935 as of November 6th. This net worth evaluation does not reflect any other investments that Mr. Kabakoff may own. Learn More about David S. Kabakoff's net …Nov 29, 2023 · The Castle Biosciences, Inc. stock price gained 1.95% on the last trading day (Wednesday, 29th Nov 2023), rising from $19.48 to $19.86. During the last trading day the stock fluctuated 3.77% from a day low at $19.61 to a day high of $20.35. The price has risen in 7 of the last 10 days and is up by 3.76% over the past 2 weeks. Nov 3, 2023 · Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new discovery data from an ongoing study exploring the potential for developing a complementary, minimally invasive test to evaluate small, suspicious lesions of uncertain malignant potential in patients’ eyes. Castle Biosciences’ technology approach objectively measures optimal combinations of epithelial, immune, and stromal processes in the context of tissue morphology to extract tissue profiles (information from digital whole side images of tissue biopsies) that are correlated with diagnosis and prognosis. Our tissue systems biology approach integrates …Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...

The stock price of Castle Biosciences, a skin cancer diagnostic company, has seen a large 24% drop over the last ten trading days, while it is down 14% over the last five trading days.Castle Biosciences offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.

Nov 30, 2023 · The latest price target for Castle Biosciences ( NASDAQ: CSTL) was reported by Keybanc on Friday, August 4, 2023. The analyst firm set a price target for 25.00 expecting CSTL to rise to within 12 ... Get the latest Castle Biosciences, Inc. (CSTL) stock news and headlines to help you in your trading and investing decisions.Nov 22, 2023 · November 22, 2023 at 3:28 AM · 2 min read. Last week, Castle Biosciences, Inc. ( NASDAQ:CSTL) insiders, who had purchased shares in the previous 12 months were rewarded handsomely. The shares ... Castle Biosciences Inc. Watch list Set a price target alert After Hours Last Updated: Nov 3, 2023 5:21 p.m. EDT Delayed quote $ 17.95 -0.03 -0.17% After Hours Volume: 7.02K Advanced Charting... 3 Haz 2023 ... The company's shares closed yesterday at $22.73. Souda covers the Healthcare sector, focusing on stocks such as Guardant Health, Repligen, and ...Belgium, a country known for its rich history, stunning architecture, and vibrant culture, offers a plethora of attractions for visitors to explore. From medieval castles to modern art galleries, Belgium has something for everyone.The estimated Net Worth of Kristen M Oelschlager is at least $2.3 Million dollars as of 28 December 2022. Ms. Oelschlager owns over 7,178 units of Castle Biosciences stock worth over $1,593,448 and over the last 2 years she sold CSTL stock worth over $710,200. In addition, she makes $0 as Senior Vice President - Clinical …

Castle Biosciences Stock Up 9.0 %. CSTL stock opened at $14.23 on Tuesday. The company has a market cap of $381.51 million, a PE ratio of -4.25 and a beta of 0.85. The business has a 50-day simple ...

Leadership: Castle Biosciences. Stock and Other Ownership Interests: Castle Biosciences. Patents, Royalties, Other Intellectual Property: Patents with Castle Biosciences. No other potential conflicts of interest were reported. OPTIONS & TOOLS. Export Citation: Track Citation: Add To Favorites: Rights & Permissions; COMPANION …

19 Nis 2023 ... Castle Biosciences, Inc., a company improving health through innovative ... Stock BITF logo. BITF · Bitfarms Announces C$60 Million Private ...Jun 5, 2023 · FRIENDSWOOD - Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data on DecisionDx-Melanoma and DecisionDx-UM will be shared during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 2-6. 2,091.70 +34.50(+1.68%) Castle Biosciences, Inc. (CSTL) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 19.97 -0.02 (-0.10%) At close: 04:00PM EST 20.35 +0.38 (+1.90%)...Castle Creek Biosciences: Cell and Gene Therapy Company : Castle Creek Biosciences, Inc. “ We are building a leading cell and gene therapy company for patients and families seeking relief from devastating genetic diseases. ”. Matthew Gantz, President and Chief Executive Officer. Courtesy of debra—The Dystrophic Epidermolysis Bullosa ...Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive …Jun 5, 2023 · Castle Biosciences (CSTL) In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on Castle Biosciences, with a price target of $38.00 . The company’s shares closed last ... In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...The estimated Net Worth of Mara G. Aspinall is at least 2.53 百万$ dollars as of 25 August 2022. Ms. Aspinall owns over 6,000 units of Castle Biosciences stock worth over 1,731,228$ and over the last 8 years she sold CSTL stock worth over 494,800$. In addition, she makes 302,714$ as Independent Director at Castle Biosciences.The estimated net worth of David S. Kabakoff is at least $3.83 million as of June 22nd, 2020. Mr. Kabakoff owns 212,178 shares of Castle Biosciences stock worth more than $3,831,935 as of November 6th. This net worth evaluation does not reflect any other investments that Mr. Kabakoff may own. Learn More about David S. Kabakoff's net …

Biosciences; Research Funding - Castle Biosciences. CPG: Other Remuneration - Indiana University. DM: President and CEO - Castle Biosciences; Stock Ownership - Castle Biosciences. KMO: Director of ...Castle Biosciences Inc (CSTL) Stock Expected to Experience Positive Growth on November 3, 2023: Analysts Predictions and Ratings. On November 3, 2023, Castle Biosciences Inc (CSTL) stock is expected to experience positive growth, according to analysts. The 8 analysts offering 12-month price forecasts for CSTL have a median …Discover historical prices for CSTL stock on Yahoo Finance. View daily, weekly or monthly format back to when Castle Biosciences, Inc. stock was issued.Instagram:https://instagram. dividend vzvision insurance wisconsinbmy dividendsotly stock forecast castle sell stock wallpaper. castle biosciences stock buy or sell. Sofinnova Healthquest Partners LP is. The target price for CSTL stock is 8343 based on the average of what a group of analyst thi… Friday, November 11, 2022 Edit. Older Posts Home. Subscribe to: Posts (Atom) Popular Posts. vh1 tv schedule passport. Grandmas in the …FRIENDSWOOD - Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data on DecisionDx-Melanoma and DecisionDx-UM will be shared during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 2-6. should i buy stocks on cash appwhy blackrock 6 Mar 2023 ... Today's Castle Biosciences Inc Share Price - Explore CSTL stock Information, latest price chart, peers growth, market trend and start ... tqqq sotck Castle Biosciences had a GAAP loss of 70 cents a share, approximately 20 cents a share above expectations. Revenues rose 44% on a year-to-year basis to $50.1 million, almost $6 million over the ...Find real-time CSTL - Castle Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business.